Meticulous Research®, a globally recognized market research firm, has published its latest report titled “ELISA Market Size, Share, Forecast & Trends Analysis by Type (Direct, Sandwich, Competitive), Offering (Analyzer, Software), Technology (Chemiluminescence, Colorimetry, Fluorescence), Application (Research, Diagnostic), End User—Global Forecast to 2031.” According to the report, the global ELISA market is expected to grow at a CAGR of 6.1%, reaching $32.69 billion by 2031.
Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5997?
The expansion of the ELISA market is driven by the increasing prevalence of chronic and infectious diseases, advancements in ELISA technology, and its growing applications in clinical and food industries. Despite these opportunities, challenges like the high costs of ELISA antibody preparation and the risk of false positives pose potential hurdles.
Opportunities and Challenges
Emerging markets, increased R&D in biomarker detection, and a growing emphasis on vaccine development offer promising growth avenues. However, stringent regulatory frameworks and the availability of alternative diagnostic technologies remain significant challenges.
Key Players
Leading companies in the ELISA market include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), Revvity Inc. (U.S.), QuidelOrtho Corporation (U.S.), Becton, Dickinson and Company (U.S.), Repligen Corporation (U.S.), BioLegend (U.S.), and Bio-Techne Corporation (U.S.).
Segment Highlights
Type: Indirect ELISA is projected to dominate with a 43.5% market share in 2024, owing to its high sensitivity and cost-effectiveness.
Offering: The kits & assays segment is set to hold the largest share (85.2%) due to increased usage in disease diagnostics and biomarker detection.
Technology: Colorimetric ELISA is expected to account for the largest share, driven by affordability and ease of use in research applications.
Application: Diagnostic applications will lead, leveraging ELISA for detecting diseases like cancer, autoimmune disorders, and infections.
End User: Diagnostic laboratories are expected to dominate, fueled by a rise in chronic diseases and an increasing number of facilities adopting ELISA tests.
Regional Insights
North America is forecasted to hold the largest regional market share in 2024, representing 37.7%. Factors contributing to this share include advanced healthcare infrastructure, robust R&D funding, and the presence of leading market players. The expansion of research facilities, such as Thermo Fisher’s $59 million investment in a Kentucky lab in 2022, underscores North America's market strength.
Buy Now: https://www.meticulousresearch.com/Checkout/88327546?
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research